OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells
Yaiza Senent, Beatriz Tavira, Rubén Pı́o, et al.
Cancer Letters (2022) Vol. 549, pp. 215900-215900
Open Access | Times Cited: 12

Showing 12 citing articles:

Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Yayuan Deng, Mengjia Shi, Yi Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37060-e37060
Open Access | Times Cited: 28

Complement factor H: a novel innate immune checkpoint in cancer immunotherapy
Ruchi Saxena, Elizabeth B. Gottlin, Michael J. Campa, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9

Interplay between the complement system and other immune pathways in the tumor microenvironment
Cecília Garlanda, Monica Dambra, Elena Magrini
Seminars in Immunology (2025) Vol. 78, pp. 101951-101951
Open Access

Structural characterization of an acid-extracted polysaccharide from Suillus luteus and the regulatory effects on intestinal flora metabolism in tumor-bearing mice
Xiaoji Gao, Yuting Fan, Keyao Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 136137-136137
Closed Access | Times Cited: 4

gC1qR: A New Target for Cancer Immunotherapy
Yanna Lei, Xiaoyu Li, Diyuan Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
Meng Yuan, Chenlin Wang, Yanan Wu, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 5, pp. 1093-1107
Open Access | Times Cited: 9

Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment
Juhee Lim, Jeongwoo La, Hyeon Cheol Kim, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110810-110810
Open Access | Times Cited: 2

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
Sonia Domingos‐Pereira, Karthik Sathiyanadan, Lenka Polák, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 123-123
Open Access | Times Cited: 8

The complement system in clinical oncology: Applications, limitations and challenges
Daniel Ajona, Mark S. Cragg, Rubén Pı́o
Seminars in Immunology (2024) Vol. 77, pp. 101921-101921
Open Access | Times Cited: 1

Inhibition of the Complement Pathway Induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma
Zanele Nsingwane, Previn Naicker, J. Omoshoro–Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top